S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
S&P 500   3,790.93
DOW   30,316.32
QQQ   282.13
6 Benefits of Working With a Franchise Consultant or Broker
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
3 Safe Earnings Plays for a Risk-Off Market
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Micron to bring microchip plant to upstate New York
Tyson Foods Takes a Lickin’ and Keeps on Tickin’ Lower
Market Wizard Who Accurately Predicted 2022 Market Collapse Has Shocking New Forecast (Ad)
Stocks rise in extended rally, clawing back more ground
Live Updates: Russia-Ukraine War
NASDAQ:NVCR

NovoCure - NVCR SEC Filings & 10K Form

$85.05
+7.17 (+9.21%)
(As of 10/4/2022 12:00 AM ET)
Add
Compare
Today's Range
$79.74
$86.30
50-Day Range
$67.99
$89.57
52-Week Range
$56.39
$124.35
Volume
633,711 shs
Average Volume
618,754 shs
Market Capitalization
$8.91 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$107.57

Recent NovoCure SEC Filings

DateFilerForm TypeView
09/30/2022
3:20 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2022
3:19 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2022
3:10 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2022
3:15 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4/A
09/12/2022
3:32 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2022
3:27 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
4:16 PM
Burke William Patrick (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
4:15 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
4:14 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
4:12 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2022
3:19 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
3:45 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
3:44 PM
DOYLE WILLIAM F (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
3:44 PM
Benaim Ely (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
3:44 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2022
4:51 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2022
4:50 PM
Ben Arye Barak (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2022
4:49 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2022
4:48 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2022
4:48 PM
Danziger Asaf (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2022
4:47 PM
Benaim Ely (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2022
4:46 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2022
4:45 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2022
4:44 PM
Burke William Patrick (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2022
3:22 PM
HILLEMAN JERYL L (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
3:15 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2022
3:09 PM
LEUNG GABRIEL (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
3:08 PM
HILLEMAN JERYL L (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2022
7:01 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2022
7:04 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2022
3:30 PM
Benaim Ely (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2022
6:04 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2022
6:03 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2022
3:16 PM
NovoCure (Filer)
Form DEFA14A
04/25/2022
3:14 PM
NovoCure (Filer)
Form DEF 14A
04/14/2022
3:36 PM
Ben Arye Barak (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2021
3:34 PM
Burke William Patrick (Reporting)
NovoCure (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/10/2021
11:28 AM
Capital International Investors (Filed by)
NovoCure (Subject)
Form SC 13G/A
08/06/2021
3:44 PM
Madden Martin J. (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2021
3:41 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2021
3:39 PM
LEUNG GABRIEL (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
4:20 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/04/2021
4:09 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2021
4:29 PM
Benaim Ely (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2021
5:10 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2021
5:09 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/08/2021
4:38 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:36 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:35 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:34 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:32 PM
Benaim Ely (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:31 PM
Danziger Asaf (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:29 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
4:23 PM
LEUNG GABRIEL (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:26 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:24 PM
McCoy Sherilyn S (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:22 PM
Madden Martin J. (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
3:16 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2021
3:36 PM
Benaim Ely (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2021
3:07 PM
Benaim Ely (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
3:13 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
11:49 AM
Capital World Investors (Filed by)
NovoCure (Subject)
Form SC 13G/A
05/05/2021
3:09 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2021
5:08 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2021
5:07 AM
NovoCure (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/27/2021
4:29 PM
NovoCure (Filer)
Form DEFA14A
04/27/2021
4:27 PM
NovoCure (Filer)
Form DEF 14A
04/15/2021
5:29 PM
DOYLE WILLIAM F (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2021
5:01 PM
Danziger Asaf (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2021
5:00 PM
LEUNG GABRIEL (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2021
4:59 PM
Benaim Ely (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2021
8:17 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2021
3:25 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4/A
03/09/2021
3:17 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2021
3:16 PM
Benaim Ely (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
3:26 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
3:25 PM
Longsworth Todd Christopher (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
3:24 PM
Leonard Frank X (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
3:23 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
4:44 PM
Benaim Ely (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2021
4:43 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:54 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:53 PM
Benaim Ely (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:52 PM
Cordova Ashley (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:50 PM
GROENHUYSEN WILHELMUS CM (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:48 PM
NovoCure (Issuer)
Scannell Timothy J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:46 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:44 PM
Longsworth Todd Christopher (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
3:18 PM
NovoCure (Issuer)
Shah Pritesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
3:17 PM
Danziger Asaf (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
5:30 AM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2021
5:27 AM
NovoCure (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2021
3:16 PM
NovoCure (Issuer)
Weinberg Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
6:11 PM
NovoCure (Issuer)
Scannell Timothy J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/08/2021
3:33 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2021
7:03 AM
BlackRock Inc. (Filed by)
NovoCure (Subject)
Form SC 13G
02/01/2021
3:19 PM
NovoCure (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2021
11:08 AM
NovoCure (Subject)
Wyss Hansjoerg (Filed by)
Form SC 13G/A
01/19/2021
4:00 PM
Longsworth Todd Christopher (Reporting)
NovoCure (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2021
11:14 AM
BAILLIE GIFFORD & CO (Filed by)
NovoCure (Subject)
Form SC 13G/A
This page (NASDAQ:NVCR) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.